BackStenocare A/S Overview

Stenocare A/S EBIT

Track Stenocare A/S's EBIT ($-620K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$335.61K
↓ 7454.94% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$622.96K
↑ 97.77% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Stenocare A/S (STENO.CO) FAQ

The latest EBIT for STENO.CO is $-620K as of June 2026. That compares with $-28M in the prior-year period — up 97.8% year over year. That is below the sector sector average of $2.6T. Investors often review this figure alongside Stenocare A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, STENO.CO's EBIT moved from $-28M to $-620K — a 97.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Stenocare A/S's operating scale or balance-sheet position.

Against its sector companies, STENO.CO currently prints $-620K for EBIT, while the sector average sits near $2.6T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Stenocare A/S's growth, margins, and balance sheet.

A EBIT figure of $-620K for STENO.CO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.6T. Explore the charts below for those layers of context.

After noting STENO.CO's EBIT ($-620K), review year-over-year change from $-28M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.